Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022332

« Back to Dashboard
NDA 022332 describes ADCIRCA, which is a drug marketed by Eli Lilly Co and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ADCIRCA profile page.

The generic ingredient in ADCIRCA is tadalafil. There are twenty-three drug master file entries for this compound. Eleven suppliers are listed for this compound. There are ten tentative approvals for this compound. Additional details are available on the tadalafil profile page.

Summary for NDA: 022332

Formulation / Manufacturing:see details

Pharmacology for NDA: 022332

Suppliers and Packaging for NDA: 022332

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TABLET;ORAL 022332 NDA United Therapeutics Corporation 66302-467 66302-467-60 60 TABLET in 1 BOTTLE (66302-467-60)
TABLET;ORAL 022332 NDA United Therapeutics Corporation 66302-467 66302-467-61 14 TABLET in 1 BOTTLE (66302-467-61)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:May 22, 2009TE:RLD:Yes
Patent:6,821,975Patent Expiration:Nov 19, 2020Product Flag?YSubstance Flag?YDelist Request?
Patent:7,182,958Patent Expiration:Apr 26, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:5,859,006Patent Expiration:Nov 21, 2017Product Flag?YSubstance Flag?YDelist Request?

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus